Trial Profile
PEARL Study (PITAVASTATIN HEART FAILURE Study).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2013
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Chronic heart failure; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms PEARL
- 17 Jul 2012 Actual end date (Jul 2012) added as reported by University Hospital Medical Information Network (Japan) record.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network (Japan) record.
- 19 Apr 2012 Trial design published in the International Journal of Cardiology.